PATENT CLAIM ANALYSIS

Application Number: 16242760
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "133100"]

Abstract:
The present invention relates to antibodies and antigen binding fragments thereof which bind to the cytokine receptor IL-22R, particularly human IL-22R. The invention also relates to pharmaceutical compositions comprising said antibodies or antigen binding fragments thereof, and methods of treating psoriasis, psoriatic arthritis or atopic dermatitis.

Claim (Index 52):
An isolated polynucleotide which encodes the variable light chain domain of an antibody or antigen binding fragment, wherein the antibody or antigen binding fragment binds to the human interleukin 22 receptor (IL-22R) protein, and the isolated polynucleotide comprises a sequence represented by any of SEQ ID NOs: 73, 75, 77, 79 or 81.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 99.0
- Lexical Diversity: 1.45714
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14163752', '14307515', '14307519', '15390067', '15192020']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8195357386815451
- 35 USC 102 Novelty (BERT): 0.5847857765958242
- Combined Prediction Score: 0.796060742472973
- Mean Citation Score: 496.6810860000001
- Max Citation Score: 521.3358
- Similarity Product: 420.84022615925073

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test